Company: PACB
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001299130-25-000102
Chunk: 162

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 162
---
,075)$(78,178)Adjustments to reconcile net loss to net cash used in operating activitiesDepreciation 5,131 3,240 Amortization of intangible assets366,390 6,853 Amortization of right-of-use assets1,258 1,921 Share-based compensation expense9,201 19,525 Impairment charges15,000 — Accretion of discount and amortization of premium on marketable securities, net(1,706)(4,031)Change in the estimated fair value of contingent consideration(18,700)(70)Inventory provision7,659 3 Deferred income taxes(546)— Other719 403 Changes in assets and liabilities Accounts receivable, net(4,121)6,292 Inventory, net(2,538)(11,655)Prepaid expenses and other assets 3,426 3,051 Accounts payable (1,525)6,644 Accrued expenses 311 (23,753)Deferred revenue 1,332 1,601 Operating lease liabilities(1,618)(2,376)Other liabilities 2,346 (5,152)Net cash used in operating activities (44,056)(75,682)Cash flows from investing activitiesPurchases of property and equipment (1,389)(3,879)Purchases of intangible assets(5,000)— Purchases of investments (61,820)(191,907)Maturities of investments 113,443 161,650 Net cash provided by (used in) investing activities 45,234 (34,136)Cash flows from financing activitiesProceeds from issuance of common stock from equity plans1,959 6,891 Notes payable principal payoff— (338)Net cash provided by financing activities 1,959 6,553 Net increase (decrease) in cash, cash equivalents, and restricted cash3,137 (103,265)Cash, cash equivalents, and restricted cash at beginning of period 57,592 182,633 Cash, cash equivalents, and restricted cash at end of period $60,729 $79,368 Cash and cash equivalents at end of period 58,507 76,646 Restricted cash at end of period 2,222 2,722 Cash, cash equivalents, and restricted cash at end of period $60,729 $79,368